Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer.
Nakajo A, Hokita S, Ishigami S, Miyazono F, Etoh T, Hamanoue M, Maenohara S, Iwashita T, Komatsu H, Satoh K, Aridome K, Morita S, Natsugoe S, Takiuchi H, Nakano S, Maehara Y, Sakamoto J, Aikou T; Kyushu Taxol TS-1 Study Group. Nakajo A, et al. Among authors: miyazono f. Cancer Chemother Pharmacol. 2008 Nov;62(6):1103-9. doi: 10.1007/s00280-008-0693-y. Epub 2008 Mar 4. Cancer Chemother Pharmacol. 2008. PMID: 18317763 Clinical Trial.
A phase I combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer.
Hokita S, Aikou T, Miyazono F, Ishigami S, Aridome K, Maenohara S, Saihara T, Suenaga K, Nomura H, Maeda S, Takatori H, Arima H, Uchikado Y, Natsugoe S, Takao S. Hokita S, et al. Among authors: miyazono f. Cancer Chemother Pharmacol. 2006 Jun;57(6):736-40. doi: 10.1007/s00280-005-0122-4. Epub 2005 Sep 15. Cancer Chemother Pharmacol. 2006. PMID: 16163539 Clinical Trial.
Clinical significance of circulating tumor cells in the response to trastuzumab for HER2-negative metastatic gastric cancer.
Matsushita D, Uenosono Y, Arigami T, Yanagita S, Okubo K, Kijima T, Miyazono F, Hamanoue M, Hokita S, Nakashima S, Ohtsuka T, Natsugoe S. Matsushita D, et al. Among authors: miyazono f. Cancer Chemother Pharmacol. 2021 Jun;87(6):789-797. doi: 10.1007/s00280-021-04251-z. Epub 2021 Feb 28. Cancer Chemother Pharmacol. 2021. PMID: 33641065
Tumor-associated macrophage (TAM) infiltration in gastric cancer.
Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Okumura H, Matsumoto M, Miyazono F, Hokita S, Aikou T. Ishigami S, et al. Among authors: miyazono f. Anticancer Res. 2003 Sep-Oct;23(5A):4079-83. Anticancer Res. 2003. PMID: 14666722
32 results